Risk factors for Fontan-associated hepatocellular carcinoma.
Risk factors for Fontan-associated hepatocellular carcinoma.
复制标题
DOI:
10.1371/journal.pone.0270230
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
中科院分区:
文献类型:
--
作者:
The incidence of hepatocellular carcinoma (HCC) in patients with Fontan-associated liver disease (i.e., FALD-HCC) has increased over time. However, the risk factors for HCC development remain unclear. Here, we compared the levels of non-invasive markers to the survival rate of FALD-HCC patients. From 2003 to 2021, 154 patients (66 men, 42.9%) developed liver disease after undergoing Fontan procedures. HCC was diagnosed in 15 (9.7%) (8 men, 53.3%) at a median age of 34 years (range, 21–45 years). We compared FALD-HCC and non-HCC cases; we generated marker level cutoffs using receiver operating characteristic curves. We sought to identify risk factors for HCC and mortality. The incidence of HCC was 4.9% in FALD patients within 20 years after the Fontan procedure. Compared with non-HCC patients, FALD-HCC patients exhibited higher incidences of polysplenia and esophageal varices. At the time of HCC development, the hyaluronic acid (HA) level (p = 0.04) and the fibrosis-4 index (p = 0.02) were significantly higher in FALD-HCC patients than in non-HCC patients; the total bilirubin (T-BIL) level (p = 0.07) and the model for end-stage liver disease score [excluding the international normalized ratio (MELD-XI)] (p = 0.06) tended to be higher in FALD-HCC patients. Within approximately 20 years of the Fontan procedure, 10 patients died (survival rate, 96.9%). Kaplan–Meier curve analysis indicated that patients with T-BIL levels ≥ 2.2 mg/dL, HA levels ≥ 55.5 ng/mL, and MELD-XI scores ≥ 18.7 were at high risk of HCC, a generally poor prognosis, and both polysplenia and esophageal varices. Multivariate Cox regression analyses indicated that the complication of polysplenia [Hazard ratio (HR): 10.915] and a higher MELD-XI score (HR: 1.148, both p < 0.01) were independent risk factors for FALD-HCC. The complication of polysplenia and a MELD-XI score may predict HCC development and mortality in FALD patients.
登录
查看更多内容
影响因子:
3.7
作者:
Abe S;Yoshihisa A;Takiguchi M;Shimizu T;Nakamura Y;Yamauchi H;Iwaya S;Owada T;Miyata M;Sato T;Suzuki S;Oikawa M;Kobayashi A;Yamaki T;Sugimoto K;Kunii H;Nakazato K;Suzuki H;Saitoh S;Takeishi Y
通讯作者:
Takeishi Y
影响因子:
5.7
作者:
Kiesewetter, Christoph H.;Sheron, Nick;Veldtman, Gruschen R.
通讯作者:
Veldtman, Gruschen R.
影响因子:
2.8
作者:
Pundi, Krishna;Pundi, Kavitha N.;Johnson, Jonathan N.
通讯作者:
Johnson, Jonathan N.
影响因子:
3.7
作者:
Isoura Y;Yamamoto A;Cho Y;Ehara E;Jogo A;Suzuki T;Amano-Teranishi Y;Kioka K;Hamazaki T;Murakami Y;Tokuhara D
通讯作者:
Tokuhara D
DOI:
10.1016/j.cgh.2009.05.033
发表时间:
2009-10
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
Shah AG;Lydecker A;Murray K;Tetri BN;Contos MJ;Sanyal AJ;Nash Clinical Research Network
通讯作者:
Nash Clinical Research Network